Genetic neuromuscular condition
Duchenne muscular dystrophy: genetics, diagnosis and care in the UK
Duchenne muscular dystrophy is an X-linked genetic condition in which muscles lack working dystrophin. It mostly affects boys, shows itself in early childhood and gets worse over time. This guide explains the genetics, the route to diagnosis and the long-term, team-based care offered in the UK.
Last checked: 2026-10-03
Key facts
At a glance.
-
Cause
Changes in the DMD gene stop the body making working dystrophin, a protein that protects muscle fibres while they contract and relax.
-
Who is affected
It is X-linked recessive, so boys are mainly affected. International estimates put Duchenne and Becker combined at roughly 1 in 3,500 to 5,000 newborn boys.
-
Course
Weakness starts in early childhood and worsens quickly compared with other muscular dystrophies. Many boys need a wheelchair by adolescence.
-
Beyond the legs
Heart muscle and breathing muscles are involved over time, so cardiac and respiratory checks are a routine part of care.
-
Treatment status
There is no cure. Care aims to protect strength, heart, lungs and spine, and the NHS lists steroids among medicines used in Duchenne.
What dystrophin does and why its absence matters
Muscle fibres are put under mechanical strain every time they shorten and lengthen. Dystrophin acts like a shock absorber, anchoring the fibre skeleton to the membrane around it. In Duchenne, changes in the DMD gene mean that little or no functional dystrophin is made, so fibres are damaged by ordinary use and are gradually replaced by scar and fat.
Because dystrophin is also present in heart muscle and, to a lesser degree, in the brain, the condition is not confined to the limbs. Some boys have learning, attention or language difficulties alongside the physical picture, and the heart is affected as the years go by.
How it is inherited
The DMD gene sits on the X chromosome. A boy has one X chromosome, so a single faulty copy is enough to cause the condition, whereas a girl would normally have a second working copy that compensates. Fathers cannot pass an X-linked change on to their sons.
Many boys inherit the change from a mother who is a carrier, but not all do. Action Duchenne explains that new changes can arise spontaneously and that germline mosaicism, where a change is present in some of a parent's egg or sperm cells without showing up in a routine blood test, can lead to a child being affected even when the parents are well.
Female carriers are not always symptom-free. Action Duchenne notes that carriers may have health considerations of their own, particularly relating to the heart, which is one reason carrier testing and cardiac assessment for female relatives is discussed in clinical genetics.
Early signs that prompt an assessment
Parents often notice that a toddler walks late, falls more than other children, finds stairs hard or cannot keep up at nursery. Calf muscles can look unusually bulky, and a child may use his hands to push up his own legs when rising from the floor, a pattern called Gowers' sign. The NHS also lists muscle weakness that worsens with age, joint stiffness and delayed crawling or walking among the features of muscular dystrophy generally.
A raised blood creatine kinase level is often the first objective clue, and a GP who suspects a muscle condition in a child will usually arrange this blood test and refer to paediatric services if it is high.
-
Delayed walking or running compared with peers
-
Frequent falls and difficulty with steps or hopping
-
Enlarged-looking calves
-
Using the hands to climb up the thighs to stand (Gowers' sign)
-
Tiptoe walking or a waddling gait
How the diagnosis is confirmed
Action Duchenne describes creatine kinase blood tests as crucial to diagnosis, with genetic testing used to confirm it and neuromuscular assessment forming part of the work-up. A muscle biopsy is now uncommon because a DNA result can usually answer the question without one.
The type of DMD gene change matters. Some are deletions or duplications of whole sections of the gene, others are small changes within it. The exact change is recorded in the genetic report because it affects which research studies and which genotype-specific medicines a family may later be told about. NHS genetic testing is free when arranged by a hospital specialist, and genetic counselling is offered alongside it.
Treatment and monitoring through childhood
The NHS describes management of muscular dystrophy as symptom-focused, with physiotherapy, medicines including steroids for Duchenne, cardiac interventions, surgery for complications and respiratory support when needed. Occupational therapy, mobility aids and home adaptations help with daily life.
In practice, care in the UK is led by a specialist neuromuscular team that brings together a paediatric neurologist, physiotherapist, cardiologist, respiratory specialist, endocrinologist, orthopaedic input and nursing support. Steroid treatment needs regular review because of effects on growth, bone strength, weight, blood pressure and mood, so those areas are watched closely.
-
Regular physiotherapy and stretching to protect joint movement
-
Scheduled heart checks, often with echocardiography and heart-rhythm assessment
-
Lung function measurement and, later, breathing support at night if needed
-
Bone health review, because steroids and reduced mobility weaken bones
-
Spine surveillance for scoliosis
Heart, breathing and the spine
MedlinePlus states that both Duchenne and Becker dystrophy involve cardiomyopathy that typically starts in adolescence and can progress to dilated cardiomyopathy. Heart medicines may be started early to protect the heart muscle rather than waiting for symptoms.
As the diaphragm and chest muscles weaken, cough becomes less effective and breathing during sleep can become shallow. Teams monitor this with lung function tests and sleep assessments and offer cough assistance and non-invasive ventilation when appropriate. Scoliosis can develop as trunk muscles weaken and may be treated with specialist spinal surgery in selected young people.
Outlook and family planning
MedlinePlus reports that boys with Duchenne often become wheelchair-dependent by adolescence and that survival has typically extended into the twenties, although care standards have been changing and individual teams will give a more current picture. Outcomes vary between boys.
Families who have had a child with Duchenne can be referred to clinical genetics to discuss carrier testing for female relatives and options in future pregnancies, including prenatal diagnosis and pre-implantation genetic testing. The NHS notes that prenatal testing is available for pregnancies at risk of muscular dystrophy.
Frequently asked
Questions people ask.
Quick, plain-English answers to the questions we hear most.
-
Can girls get Duchenne muscular dystrophy?
It is rare. Girls usually have a second working copy of the DMD gene and are often carriers without major weakness, although some carriers develop muscle or heart symptoms and are offered cardiac checks.
-
Is Duchenne always inherited from the mother?
No. Many cases follow a family pattern, but Action Duchenne explains that new changes in the gene and germline mosaicism also occur, so a child can be affected without any family history.
-
What is the first test for suspected Duchenne?
A blood test for creatine kinase, usually followed by genetic testing of the DMD gene. Muscle biopsy is now uncommon.
-
Are steroids used?
The NHS lists steroids among medicines used for Duchenne. A specialist team decides when to start, how to monitor side effects and whether to adjust or stop treatment.
-
Does Duchenne affect thinking and learning?
Some boys have difficulties with attention, language or learning, because dystrophin is also present in the brain. Not every boy is affected, and schools and educational psychologists can help adapt support.
-
Is the heart always affected?
Cardiomyopathy typically begins in adolescence in Duchenne and Becker types, so regular heart checks are planned in advance rather than waiting for symptoms.
-
What is the difference between Duchenne and Becker?
Both involve the DMD gene. Duchenne produces little or no working dystrophin and is more severe, whereas Becker produces a partly working protein, so symptoms are milder and start later.
-
Can the condition be detected in pregnancy?
Yes. The NHS notes that prenatal testing is available for pregnancies known to be at risk. Clinical genetics can discuss the options.
-
Who should be told if a boy is diagnosed?
Female relatives on the mother's side may wish to be offered carrier testing. A genetic counsellor can explain which relatives could be affected and how to share the information.
Where this comes from
Sources and checking.
This guide is for information, not medical advice.
Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.
Published 2026-10-03, next review 2027-10-03.
-
NHS: Muscular dystrophy (https://www.nhs.uk/conditions/muscular-dystrophy/), retrieved October 2026
-
MedlinePlus Genetics: Duchenne and Becker muscular dystrophy (https://medlineplus.gov/genetics/condition/duchenne-and-becker-muscular-dystrophy/), retrieved October 2026
-
Action Duchenne: Diagnosis of Duchenne muscular dystrophy (https://www.actionduchenne.org/diagnosis-of-duchenne-muscular-dystrophy/), retrieved October 2026
-
Action Duchenne: How is Duchenne muscular dystrophy inherited? (https://www.actionduchenne.org/how-is-duchenne-muscular-dystrophy-inherited/), retrieved October 2026
-
Action Duchenne: Signs and symptoms of Duchenne muscular dystrophy (https://www.actionduchenne.org/signs-and-symptoms-of-duchenne-muscular-dystrophy/), retrieved October 2026
-
NHS: Genetic and genomic testing (https://www.nhs.uk/tests-and-treatments/genetic-and-genomic-testing/), retrieved October 2026
Related guides
Keep reading.
-
Muscular dystrophy overview
The wider group of conditions and how they are managed.
Read guide -
Creatine kinase test
The blood test that flags muscle damage.
Read guide -
Genetic counselling: what happens
What a counselling appointment covers.
Read guide -
Neurological rehabilitation
Therapy-led support for long-term neurological conditions.
Read guide -
Dilated cardiomyopathy
Heart muscle enlargement and weakness.
Read guide